rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
9539
|
pubmed:dateCreated |
2006-9-11
|
pubmed:abstractText |
Despite the prognostic value of metabolic syndrome for predicting cardiovascular events, few trials have investigated the effects of statin therapy on cardiovascular morbidity and mortality in patients with the metabolic syndrome. Our post hoc analysis of the Treating to New Targets (TNT) study assessed whether intensive lowering of low-density lipoprotein cholesterol with high-dose atorvastatin therapy results in cardiovascular benefits for patients with both coronary heart disease and the metabolic syndrome.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1474-547X
|
pubmed:author |
pubmed-author:BarterPhilipP,
pubmed-author:CarmenaRafaelR,
pubmed-author:DeedwaniaPrakashP,
pubmed-author:FruchartJean-CharlesJC,
pubmed-author:GrundyScott MSM,
pubmed-author:HaffnerStevenS,
pubmed-author:KasteleinJohn J PJJ,
pubmed-author:LaRosaJohn CJC,
pubmed-author:SchachnerHollyH,
pubmed-author:ShepherdJamesJ,
pubmed-author:Treating to New Targets Investigators,
pubmed-author:WatersDavid DDD
|
pubmed:issnType |
Electronic
|
pubmed:day |
9
|
pubmed:volume |
368
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
919-28
|
pubmed:dateRevised |
2007-1-18
|
pubmed:meshHeading |
pubmed-meshheading:16962881-Adult,
pubmed-meshheading:16962881-Aged,
pubmed-meshheading:16962881-Anticholesteremic Agents,
pubmed-meshheading:16962881-Cardiovascular Diseases,
pubmed-meshheading:16962881-Cholesterol, LDL,
pubmed-meshheading:16962881-Coronary Disease,
pubmed-meshheading:16962881-Diabetes Complications,
pubmed-meshheading:16962881-Dose-Response Relationship, Drug,
pubmed-meshheading:16962881-Double-Blind Method,
pubmed-meshheading:16962881-Female,
pubmed-meshheading:16962881-Heptanoic Acids,
pubmed-meshheading:16962881-Humans,
pubmed-meshheading:16962881-Male,
pubmed-meshheading:16962881-Metabolic Syndrome X,
pubmed-meshheading:16962881-Middle Aged,
pubmed-meshheading:16962881-Pyrroles,
pubmed-meshheading:16962881-Risk Factors
|
pubmed:year |
2006
|
pubmed:articleTitle |
Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study.
|
pubmed:affiliation |
Veterans Affairs Central California Healthcare System and University of California San Francisco School of Medicine, San Francisco, CA, USA. pdeedwania@fresno.ucsf.edu
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|